jamesi õhukese polümeerikattega tablett
zentiva k.s. - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 56tk; 850mg+50mg 60tk; 850mg+50mg 28tk
asigefort õhukese polümeerikattega tablett
tad pharma gmbh - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 14tk; 1000mg+50mg 56tk
asigefort õhukese polümeerikattega tablett
tad pharma gmbh - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 14tk; 850mg+50mg 200tk
jivolar õhukese polümeerikattega tablett
medochemie limited - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 168tk; 1000mg+50mg 56tk; 1000mg+50mg 180tk; 1000mg+50mg 196tk; 1000mg+50mg 30tk; 1000mg+50mg 112tk
jivolar õhukese polümeerikattega tablett
medochemie limited - metformiin+sitagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 180tk; 850mg+50mg 28tk; 0+50mg 14tk; 850mg+50mg 112tk; 850mg+50mg 30tk
vilspox õhukese polümeerikattega tablett
ideal trade links uab - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 850mg+50mg 120tk; 850mg+50mg 90tk; 850mg+50mg 30tk; 850mg+50mg 60tk
vilspox õhukese polümeerikattega tablett
ideal trade links uab - metformiin+vildagliptiin - õhukese polümeerikattega tablett - 1000mg+50mg 30tk; 1000mg+50mg 120tk; 1000mg+50mg 90tk
competact
cheplapharm arzneimittel gmbh - pioglitazone, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - competact is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients, who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.
vipdomet
takeda pharma a/s - alogliptin bensoaat, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - vipdomet is indicated in the treatment of adult patients aged 18 years and older with type-2 diabetes mellitus:as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin;in combination with pioglitazone (i. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and pioglitazone;in combination with insulin (i. kolmekordne kombineeritud ravi) lisandina toitumise ja treeningu parandamiseks glycaemic kontrolli patsientidel, kui insuliini kell stabiilne annus ja metformiin üksi ei taga piisavat kontrolli glycaemic.
glucophage sr toimeainet prolongeeritult vabastav tablett
merck sante s.a.s. - metformiin - toimeainet prolongeeritult vabastav tablett - 500mg 56tk